This week, we chat with Senior Editor Andrew Tarantola about Neuralink, Elon Musk’s brain computer interface (BCI) company. The FDA reportedly denied approval for human trials last week—Andy explains why that happened, as well as what BCIs could mean for humans in the future. Also, Cherlynn dives into the accessibility news from Microsoft’s Ability Summit.
Listen below or subscribe on your podcast app of choice. If you've got suggestions or topics you'd like covered on the show, be sure to email us or drop a note in the comments! And be sure to check out our other podcasts, the Morning After and Engadget News!